Trading Halt

Key points

• Pending announcement on proposed capital raising
• Trading halt to remain until earlier of announcement or market open on 31 Jan 2025
• Company not aware of any reason why trading halt should not be granted

Full summary

Nova Eye Medical Ltd has requested a trading halt in its securities (ASX code: EYE) from the commencement of trading on Wednesday, 29 January 2025. The trading halt has been requested pending an announcement in relation to a proposed capital raising. Nova Eye has requested that the trading halt remain in place until the earlier of such time it makes an announcement to the market in relation to the capital raising and the commencement of trading on Friday, 31 January 2025. The company has advised that it is not aware of any reason why the trading halt should not be granted and that it is not aware of any other information that is necessary to inform the market about the trading halt.